NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 3 filers reported holding NEWLINK GENETICS CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $215,000 | -71.4% | 84,988 | -82.0% | 0.01% | -66.7% |
| Q3 2019 | $751,000 | +5.0% | 472,422 | -2.3% | 0.02% | +20.0% |
| Q2 2019 | $715,000 | -21.8% | 483,384 | +2.0% | 0.02% | -25.0% |
| Q1 2019 | $914,000 | +0.8% | 473,761 | -20.6% | 0.02% | -16.7% |
| Q4 2018 | $907,000 | +12.7% | 596,705 | +83.7% | 0.02% | +41.2% |
| Q3 2018 | $805,000 | +90.8% | 324,781 | +269.1% | 0.02% | +112.5% |
| Q2 2018 | $422,000 | +145.3% | 88,000 | +271.3% | 0.01% | +100.0% |
| Q1 2018 | $172,000 | -56.9% | 23,700 | -50.9% | 0.00% | -55.6% |
| Q4 2017 | $399,000 | -85.1% | 48,251 | -67.2% | 0.01% | -88.3% |
| Q1 2016 | $2,679,000 | -65.5% | 147,205 | -30.7% | 0.08% | -57.9% |
| Q4 2015 | $7,765,000 | +42.4% | 212,525 | +39.7% | 0.18% | +6.4% |
| Q3 2015 | $5,453,000 | -13.4% | 152,148 | +7.0% | 0.17% | +0.6% |
| Q2 2015 | $6,295,000 | – | 142,187 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |